Thrombin generation determined by calibrated automated thrombography (CAT) in pediatric patients with congenital heart disease

Abstract Introduction Thrombin generation was studied in pediatric patients with congenital heart disease (CHD) undergoing cardiac surgery using the calibrated automated thrombography (CAT) in terms of the lag time until the onset of thrombin formation, time to thrombin peak maximum (TTP), endogenous thrombin potential (ETP), and thrombin peak height. The possible suitability to determine the coagulation status of these patients was investigated. Materials and methods CAT data of 40 patients with CHD (age range from newborn to 18 years) were compared to data using standard coagulation parameters such as prothrombin (FII), antithrombin (AT), tissue factor pathway inhibitor (TFPI), prothrombin fragment 1.2 (F 1.2), thrombin–antithrombin (TAT), activated partial thromboplastin time (aPTT), and prothrombin time (PT). Results A significant positive correlation was seen between ETP and FII ( p < 0.01; r = 0.369), as well as between peak height and F II ( p < 0.01; r = 0.483). A significant negative correlation was seen between ETP and TFPI values ( p < 0.05; r = − 0.225) while no significant correlation was seen between peak height and TFPI. A significant negative correlation was seen between F 1.2 generation and ETP ( p < 0.05; r = − 0.254) and between F 1.2 generation and peak height ( p < 0.05; r = − 0.236). No correlation was seen between AT and ETP or peak. Conclusions Our data indicate that CAT is a good global test reflecting procoagulatory and inhibitory factors of the hemostatic system in pediatric patients with CHD.